The positive allosteric modulator BPAM344 and L‐glutamate introduce an active‐like structure of the ligand‐binding domain of GluK2

Yasmin Bay,Mie Egeberg Jeppesen,Karla Frydenvang,Pierre Francotte,Bernard Pirotte,Darryl S. Pickering,Anders Skov Kristensen,Jette Sandholm Kastrup
DOI: https://doi.org/10.1002/1873-3468.14824
2024-02-20
FEBS Letters
Abstract:X‐ray crystallography was used to determine an active‐like dimer of the ligand‐binding domain of GluK2, locating the positive allosteric modulator BPAM344 within the dimeric interface. Selected residues T535 and Q786 differing between GluK2 and GluA2 were investigated with calcium‐sensitive fluorescence‐based assays on transiently transfected cells. A three‐fold increase in BPAM344 potency occurred with the double mutant T535S‐Q786S in GluK2(Q). Kainate receptors belong to the family of ionotropic glutamate receptors and contribute to the majority of fast excitatory neurotransmission. Consequently, they also play a role in brain diseases. Therefore, understanding how these receptors can be modulated is of importance. Our study provides a crystal structure of the dimeric ligand‐binding domain of the kainate receptor GluK2 in complex with L‐glutamate and the small‐molecule positive allosteric modulator, BPAM344, in an active‐like conformation. The role of Thr535 and Gln786 in modulating GluK2 by BPAM344 was investigated using a calcium‐sensitive fluorescence‐based assay on transiently transfected cells expressing GluK2 and mutants hereof. This study may aid in the design of compounds targeting kainate receptors, expanding their potential as targets for the treatment of brain diseases.
cell biology,biochemistry & molecular biology,biophysics
What problem does this paper attempt to address?